These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3381266)

  • 41. Cyclosporine A in treatment of membranous lupus nephropathy.
    Hu W; Liu Z; Shen S; Li S; Yao X; Chen H; Li L
    Chin Med J (Engl); 2003 Dec; 116(12):1827-30. PubMed ID: 14687467
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Medical treatment of severe uveitis].
    Berche M; Najjar G; Renard Y; Darwiche A; Musitelli E
    Ophtalmologie; 1989; 3(1):37-9. PubMed ID: 2641067
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A comparison of the effectiveness of cyclosporine A, D, and G in the treatment of experimental autoimmune uveitis in rats.
    Nussenblatt RB; Caspi RR; Dinning WJ; Palestine AG; Hiestand P; Borel J
    J Immunopharmacol; 1986; 8(3):427-35. PubMed ID: 3489788
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Infliximab in the treatment of refractory posterior uveitis.
    Joseph A; Raj D; Dua HS; Powell PT; Lanyon PC; Powell RJ
    Ophthalmology; 2003 Jul; 110(7):1449-53. PubMed ID: 12867408
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Outcome of intravitreal triamcinolone in uveitis.
    Kok H; Lau C; Maycock N; McCluskey P; Lightman S
    Ophthalmology; 2005 Nov; 112(11):1916.e1-7. PubMed ID: 16171868
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Therapeutic regimen in Vogt-Koyanagi-Harada syndrome].
    Yang P; Wang H; Zhou H; Zhong H; Li F; Huang X; Zhong H; Fu T
    Zhonghua Yan Ke Za Zhi; 2002 Apr; 38(4):196-9. PubMed ID: 12133384
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Does lowering hyperhomocysteinemia by folic acid beneficial for oculo-Behcet's disease? A pilot study.
    Houman MH; Naffati H; Khanfir M; Ghannouchi M; Ben Ghorbel I; Lamloum M; El Matri L; Hamzaoui K; Jeddi A; Miled M; Fki M
    Tunis Med; 2007 Jun; 85(6):450-3. PubMed ID: 17644895
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Reimplantation of a fluocinolone acetonide sustained drug delivery implant for chronic uveitis.
    Jaffe GJ
    Am J Ophthalmol; 2008 Apr; 145(4):667-675. PubMed ID: 18226800
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Diltiazem co treatment with cyclosporine for induction of disease remission in sight-threatening non-infectious intraocular inflammation.
    Shalaby U
    Jpn J Ophthalmol; 2017 Mar; 61(2):169-178. PubMed ID: 27943089
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cyclosporine therapy for uveitis: long-term followup.
    Nussenblatt RB; Palestine AG; Chan CC
    J Ocul Pharmacol; 1985; 1(4):369-82. PubMed ID: 3880086
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Treatment of severe uveitis with cyclosporin A].
    Harada T; Sugita K; Saito A; Awaya S
    Ophthalmologica; 1987; 195(1):21-5. PubMed ID: 3658332
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Bromocriptine: a new therapy concept in the treatment of chronic recurrent uveitis?].
    Zierhut M; Pleyer U; Waetjen R; Thiel HJ; Weidle EG
    Klin Monbl Augenheilkd; 1989 Oct; 195(4):221-5. PubMed ID: 2585998
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cyclosporin A in the treatment of severe Behçet's uveitis.
    Binder AI; Graham EM; Sanders MD; Dinning W; James DG; Denman AM
    Br J Rheumatol; 1987 Aug; 26(4):285-91. PubMed ID: 3300835
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Hemosorption in multimodal treatment of endogenous uveitis].
    Katsnel'son LA; Kaliberdina AF; Tankovskiĭ VE; Teplinskaia LE; Slepova OS; Dmitriev AA
    Vestn Oftalmol; 1991; 107(2):35-8. PubMed ID: 1858228
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cyclosporine in autoimmune diseases.
    Bach JF
    Transplant Proc; 1989 Jun; 21(3 Suppl 1):97-113. PubMed ID: 2741212
    [No Abstract]   [Full Text] [Related]  

  • 56. A masked, randomized, dose-response study between cyclosporine A and G in the treatment of sight-threatening uveitis of noninfectious origin.
    Nussenblatt RB; de Smet MD; Rubin B; Freidlin V; Whitcup SM; Davis J; Herman D; Bloom JN; Sran PK; Whitcher S
    Am J Ophthalmol; 1993 May; 115(5):583-91. PubMed ID: 8488909
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Randomized, double-masked study of cyclosporine compared to prednisolone in the treatment of endogenous uveitis.
    Nussenblatt RB; Palestine AG; Chan CC; Stevens G; Mellow SD; Green SB
    Am J Ophthalmol; 1991 Aug; 112(2):138-46. PubMed ID: 1867297
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Treatment of intraocular inflammatory disease with cyclosporin A.
    Nussenblatt RB; Palestine AG; Rook AH; Scher I; Wacker WB; Gery I
    Lancet; 1983 Jul; 2(8344):235-8. PubMed ID: 6135075
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cyclosporin in the treatment of severe chronic idiopathic uveitis.
    de Vries J; Baarsma GS; Zaal MJ; Boen-Tan TN; Rothova A; Buitenhuis HJ; Schweitzer CM; de Keizer RJ; Kijlstra A
    Br J Ophthalmol; 1990 Jun; 74(6):344-9. PubMed ID: 2198928
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [The administration of preparations into the vorticose vein in the combined therapy of severe forms of uveitis].
    Pen'kov MA; Zubarev SF; Avrushchenko NM; Saitov MA
    Oftalmol Zh; 1989; (5):278-81. PubMed ID: 2586972
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.